The Indian Pharmacopoeia Commission (IPC) has signed an MoU with the Uttar Pradesh Promote Pharma Council (UPPPC) to strengthen the pharmaceutical and medical device ecosystem.
The Indian Pharmacopoeia Commission (IPC) has signed an MoU with the Uttar Pradesh Promote Pharma Council (UPPPC) to strengthen the pharmaceutical and medical device ecosystem.
According to the 8th edition of the 'Trade Watch Quarterly (TWQ)' released by the NITI Aayog for Q4 FY26, the total merchandise and services trade of India expanded by 5.4% to $1.84 trillion.
The report states that the global pharmaceutical market recorded a demand of $1.3 trillion in 2025. India's pharmaceutical sector contributes over 1.7% to the national Gross Domestic Product (GDP) and 7.2% to the manufacturing Gross Value Added (GVA).
Novartis India has launched 'Pluvicto', the first regulatory authority-approved radioligand therapy (RLT) in India for advanced prostate cancer.
This precision medicine is indicated for patients with Prostate-Specific Membrane Antigen (PSMA)-positive metastatic castration-resistant prostate cancer (mCRPC).
PM Narendra Modi has visited Gujarat, where he inaugurated and laid the foundation stone for various development projects in Surat worth ₹18,800 crore, aimed at strengthening road connectivity, power infrastructure, and industrial development.
He also virtually inaugurated the first ‘World Yogasana Championship’ in Ahmedabad, which is recognised as a UNESCO World Heritage City.
Key projects include Packages VI and VII of the Vadodara-Mumbai Expressway, a 200-bed Employees’ State Insurance Corporation (ESIC) Hospital, a transmission network expansion project, and Chemical and Bulk Drug Zone projects in Valsad and Bharuch.
The Karnataka government has launched India’s first integrated technology-driven monitoring portal to track ‘Not of Standard Quality’ (NSQ) medicines and regulate ‘Narcotic Drugs and Psychotropic Substances’ (NDPS) drugs.
This initiative aims to strengthen drug surveillance, enhance transparency, and ensure public safety.
The Indian Pharmacopoeia Commission (IPC) has signed MoUs with the State Pharmacy Councils of Bihar, Maharashtra, and Mizoram to strengthen medicine safety, promote rational drug use, and enhance pharmacovigilance activities across India.
The National Institute of Pharmaceutical Education and Research (NIPER) in Raebareli has signed an MoU, a Confidential Disclosure Agreement (CDA), and a Technology Transfer Agreement with the Hyderabad-based Lofty Laboratories.
The collaboration aims to promote research, innovation, and technology commercialisation to strengthen the ties between academia and industry in the pharmaceutical and biotechnology sectors.
The National Institute of Pharmaceutical Education and Research (NIPER) in Mohali has signed a grant agreement with Novartis Healthcare Pvt Ltd (NHPL) to implement the “Development Pioneer Grant”.
The initiative aims to strengthen industry-academia synergy by providing financial backing for research-oriented projects. It will also support faculty research and enhance innovation and Research and Development (R&D) capabilities at the institute.